SNNA
Sienna Biopharmaceuticals, Inc.
SNNA
SNNA
Delisted
SNNA was delisted on the 16th of December, 2019.
52 hedge funds and large institutions have $184M invested in Sienna Biopharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
52
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$7.68M | |
| 2 | +$5.55M | |
| 3 | +$3.39M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$3.02M |
| 5 |
Morgan Stanley
New York
|
+$2.94M |
Top Sellers
| 1 | -$5.33M | |
| 2 | -$2.59M | |
| 3 | -$1.45M | |
| 4 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
-$484K |
| 5 |
PCM
Prelude Capital Management
New York
|
-$254K |